CA Patent

CA2768307C — Certain chemical entities, compositions and methods

Assigned to Intellikine LLC · Expires 2018-02-13 · 8y expired

What this patent protects

A compound of Formula V-A: Formula V-A or a pharmaceutically acceptable salt thereof, wherein B is a moiety of Formula II: Formula II wherein W c is aryl, heteroaryl, heterocycloalkyl, or cycloalkyl; q is an integer of 0 or 1; R1 is hydrogen, alkyl, or halo; R2 is alkyl or halo; …

USPTO Abstract

A compound of Formula V-A: Formula V-A or a pharmaceutically acceptable salt thereof, wherein B is a moiety of Formula II: Formula II wherein W c is aryl, heteroaryl, heterocycloalkyl, or cycloalkyl; q is an integer of 0 or 1; R1 is hydrogen, alkyl, or halo; R2 is alkyl or halo; R3 is halo; R9 is hydrogen, alkyl, or heterocycloalkyl; wherein alkyl is optionally substituted with one or more halo.

Drugs covered by this patent

Patent Metadata

Patent number
CA2768307C
Jurisdiction
CA
Classification
—
Expires
2018-02-13
Drug substance claim
No
Drug product claim
No
Assignee
Intellikine LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.